Dalin Zhang

687 total citations
25 papers, 495 citations indexed

About

Dalin Zhang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Dalin Zhang has authored 25 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Dalin Zhang's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Research and Splicing (5 papers). Dalin Zhang is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Research and Splicing (5 papers). Dalin Zhang collaborates with scholars based in China, United States and United Kingdom. Dalin Zhang's co-authors include Wenwu Dong, Zhihong Wang, Hao Zhang, Ping Zhang, Jiapeng Huang, Wei Sun, Liang He, Chengzhou Lv, Xiaoyu Ji and Liang Shao and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Dalin Zhang

22 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalin Zhang China 12 364 202 52 51 43 25 495
Shiduo Song China 15 308 0.8× 159 0.8× 101 1.9× 47 0.9× 36 0.8× 27 534
Jiaqi Yang China 8 232 0.6× 129 0.6× 75 1.4× 29 0.6× 14 0.3× 23 373
Teng Wang China 13 248 0.7× 136 0.7× 46 0.9× 33 0.6× 9 0.2× 26 401
Mehdi Amiri Canada 12 373 1.0× 50 0.2× 52 1.0× 47 0.9× 16 0.4× 29 518
Xiaohan Sun China 15 326 0.9× 92 0.5× 59 1.1× 32 0.6× 17 0.4× 51 553
Pushkar Malakar India 10 673 1.8× 488 2.4× 27 0.5× 21 0.4× 8 0.2× 26 793
Pengcheng Li China 12 179 0.5× 109 0.5× 60 1.2× 30 0.6× 9 0.2× 23 351

Countries citing papers authored by Dalin Zhang

Since Specialization
Citations

This map shows the geographic impact of Dalin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalin Zhang more than expected).

Fields of papers citing papers by Dalin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalin Zhang. The network helps show where Dalin Zhang may publish in the future.

Co-authorship network of co-authors of Dalin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Dalin Zhang. A scholar is included among the top collaborators of Dalin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalin Zhang. Dalin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Dalin, Hongjuan Zhao, Yi Wei, et al.. (2025). Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone. Clinical Cancer Research. 31(7). 1346–1358. 1 indexed citations
2.
Zhang, Dalin, Fernando Jose Garcia-Marques, Abel Bermudez, et al.. (2025). Identification of Molecular Subtypes of Clear-Cell Renal Cell Carcinoma in Patient-Derived Xenografts Using Multi-Omics. Cancers. 17(8). 1361–1361.
3.
Zhang, Dalin, Ru Wen, Fernando Jose Garcia-Marques, et al.. (2025). FTO inhibition attenuates renal fibrosis by downregulating ferroptosis activator ACSL4 and profibrotic factor TGFBI. iScience. 28(10). 113515–113515.
4.
He, Liang, et al.. (2024). Exploring the bidirectional relationship between metabolic syndrome and thyroid autoimmunity: a Mendelian randomization study. Frontiers in Endocrinology. 15. 1325417–1325417. 3 indexed citations
5.
Li, Caiyun G., Erik Verschueren, Ru Wen, et al.. (2023). NUSAP1 Binds ILF2 to Modulate R-Loop Accumulation and DNA Damage in Prostate Cancer. International Journal of Molecular Sciences. 24(7). 6258–6258. 16 indexed citations
6.
Liang, Yuan, et al.. (2022). A four-enhancer RNA-based prognostic signature for thyroid cancer. Experimental Cell Research. 412(2). 113023–113023. 9 indexed citations
7.
Dong, Wenwu, et al.. (2022). Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies. Frontiers in Endocrinology. 13. 971213–971213. 23 indexed citations
8.
Huang, Jiapeng, Wei Sun, Zhihong Wang, et al.. (2022). FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. Journal of Experimental & Clinical Cancer Research. 41(1). 42–42. 141 indexed citations
9.
Yao, Hui, Dalin Zhang, Hao Yu, et al.. (2022). The microbiota-gut-brain axis in pathogenesis of depression: A narrative review. Physiology & Behavior. 260. 114056–114056. 15 indexed citations
10.
Wen, Ru, et al.. (2022). Sialylated glycoproteins as biomarkers and drivers of progression in prostate cancer. Carbohydrate Research. 519. 108598–108598. 14 indexed citations
11.
Zhang, Dalin, et al.. (2022). The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma. Translational Oncology. 25. 101518–101518. 10 indexed citations
12.
Liang, Yuan, et al.. (2021). Superenhancer–transcription factor regulatory network in malignant tumors. Open Medicine. 16(1). 1564–1582. 2 indexed citations
13.
Ma, Zhao, Jin Li, Kai Lin, et al.. (2020). Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy. Nature Communications. 11(1). 4615–4615. 36 indexed citations
14.
Zhang, Dalin, Jiamei Wang, Xin Du, et al.. (2020). BAG5 promotes invasion of papillary thyroid cancer cells via upregulation of fibronectin 1 at the translational level. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(9). 118715–118715. 18 indexed citations
15.
Zhang, Dalin, Jiamei Wang, Jingyi Jiang, et al.. (2020). TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells. Cell Death and Disease. 11(9). 813–813. 24 indexed citations
16.
Zhang, Dalin, Li-Wei Qu, Bo Zhou, Guizhen Wang, & Guang‐Biao Zhou. (2017). Genomic variations in the counterpart normal controls of lung squamous cell carcinomas. Frontiers of Medicine. 12(3). 280–288. 11 indexed citations
17.
Lan, Xiabin, Hao Zhang, Zhihong Wang, et al.. (2015). Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma. Gene. 569(1). 109–117. 76 indexed citations
18.
19.
Rashid, Mohammed H., Chythanya Rajanna, Dalin Zhang, et al.. (2003). Role of exopolysaccharide, the rugose phenotype and VpsR in the pathogenesis of epidemic Vibrio cholerae. FEMS Microbiology Letters. 230(1). 105–113. 28 indexed citations
20.
Zhang, Dalin, et al.. (2003). Analysis of theVibriopathogenicity island-encoded Mop protein suggests a pleiotropic role in the virulence of epidemicVibrio cholerae. FEMS Microbiology Letters. 225(2). 311–318. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiduo Song Breakdown of academic impact, for papers by Jiaqi Yang Breakdown of academic impact, for papers by Teng Wang Breakdown of academic impact, for papers by Mehdi Amiri Breakdown of academic impact, for papers by Xiaohan Sun Breakdown of academic impact, for papers by Pushkar Malakar Breakdown of academic impact, for papers by Pengcheng Li
Rankless by CCL
2026